EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV. - Wikidata - awgldk - TriplyDB

EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.

EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.

http://www.wikidata.org/entity/Q33237979

about

NRP1 function and targeting in neurovascular development and eye disease Animal models of age related macular degeneration Retinal vasculature of adult zebrafish: in vivo imaging using confocal scanning laser ophthalmoscopy.Characterisation of a C1qtnf5 Ser163Arg knock-in mouse model of late-onset retinal macular degeneration LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages.Apelin is required for non-neovascular remodeling in the retina.Gene transfer for neovascular age-related macular degeneration.Gene therapy for ocular diseases Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy.Republished review: Gene therapy for ocular diseases.Functional and anatomic consequences of subretinal dosing in the cynomolgus macaque Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes Gene Therapies for Neovascular Age-Related Macular Degeneration.Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.Molecular pathogenesis of retinal and choroidal vascular diseases.Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice.Technical brief: subretinal injection and electroporation into adult mouse eyes.Subretinal delivery and electroporation in pigmented and nonpigmented adult mouse eyes.Flow cytometric analysis of inflammatory and resident myeloid populations in mouse ocular inflammatory models Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study.Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals.Ocular gene delivery using lentiviral vectors.Gene transfer for ocular neovascularization and macular edema.Gene delivery nanoparticles to modulate angiogenesis.Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.Retinal transduction profiles by high-capacity viral vectors.VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.

P2860

Q26765952-4DF38AF7-F909-4D46-B4A4-F64F3889765D Q27004686-633E5086-C240-414E-AE44-BCC2BE032768 Q27311464-15C0E88E-D2D5-4B38-9673-E1D2E324409A Q28478012-5ADFE670-D1BB-4B38-A191-1C9D3311C905 Q28508560-3489975E-6F46-4D8B-AD4E-2105959BA295 Q33478316-1E8450DA-2D73-41BB-AE6D-5BC5E6B8465A Q34070170-73730088-0F28-481A-A498-9F97167EEB3F Q34843778-300A3AA0-9117-46D1-B09E-54056C99C4FF Q35160142-879F2BDF-D238-4BCA-9D01-D8D8297A8720 Q35188790-BA585183-26BD-43CA-ADD2-CEC8FB426E24 Q35210756-22883425-D0BB-499D-BA78-6F1AAEA8F1BD Q35663467-DE4E74EC-051A-4B47-B752-584EB84B030A Q35762984-17347217-D575-4854-A49F-BD24D8D73229 Q35795572-B4A6C8AB-9E90-408D-A370-B8272D5350E7 Q35954001-3DE739B2-A7EA-4232-9F36-765DBEA3BBAC Q36296789-9BD50800-B864-4815-9577-1411481A1D79 Q36384723-AA68DAA4-ED3C-4B1C-9A89-4D4F8E713916 Q36904857-CDE9026D-7233-42EE-9F99-77440D5A553D Q36995732-C0A26ABD-F31B-4FA0-B576-E540412265D0 Q37043579-A4D38722-56F3-4E61-BA64-22081772B0A8 Q37316781-FB30B3E5-9DBB-465F-8F1D-563FCEACE33C Q37613100-17E31F8F-DC5B-4CF8-A991-17C7058B50EB Q37882685-3CAD6B98-5F90-443B-812A-1FEDA7525B27 Q37952564-D80C8FA9-D0A9-47D6-A2F1-AEC2D5E68238 Q37954532-1B724343-44D3-499F-B2AF-5C50A921B7C9 Q39027588-4D952C8B-29FE-4688-AB24-76252C789154 Q39877047-1542CF8E-E8B7-4E60-8522-0D9883FBA393 Q42208596-D31734D1-F75A-411A-A6AD-EC339EAC06D4 Q42292864-463AEBEC-BE49-4CE7-B7B2-6A6A703FDFD6

P2860

EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.

http://www.wikidata.org/entity/Q33237979

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

EIAV vector-mediated delivery ...... meability in experimental CNV.

@ast

EIAV vector-mediated delivery ...... meability in experimental CNV.

@en

type

label

EIAV vector-mediated delivery ...... meability in experimental CNV.

@ast

EIAV vector-mediated delivery ...... meability in experimental CNV.

@en

prefLabel

EIAV vector-mediated delivery ...... meability in experimental CNV.

@ast

EIAV vector-mediated delivery ...... meability in experimental CNV.

@en

P1433

Q33237979-21E2F8D8-9557-48AA-9B61-89639D14F33B

P1476

Q33237979-4F994CBE-FAA2-4557-ABFF-1FC53FA43E57

P2093

Q33237979-064FBA1B-A7AE-4FE2-9D52-2CE8FA01C02D

Q33237979-0D7C0A40-7BCF-49D9-B607-5202D1670CA0

Q33237979-22ED7080-178C-4D54-9863-EA8626CAAB59

Q33237979-2A3A574C-C659-4963-B4FB-C05E4FBB260B

Q33237979-44E04BB3-C2C0-408B-832B-03BA2A194ECE

Q33237979-7D54B675-6453-4385-8DB3-DC3F707BC9BA

Q33237979-7E1B6601-5D75-4242-B234-FF8BC4484D94

Q33237979-8A2CEB82-4673-4145-931A-5DAA01AB7376

Q33237979-A14657C1-44BA-49B8-A451-1B831702384F

Q33237979-CC82E1AA-196A-49A2-8C44-671653963B92

P2860

Q33237979-099CD5F1-9675-464B-AB86-050A5D837E81

Q33237979-09F24104-DB8C-415B-A5DD-733D69CE7A89

Q33237979-1D6362D8-D141-40DB-AAC3-E67D76C9C9EC

Q33237979-1E5A59CA-97A9-4575-816F-99F0E3F74ACF

Q33237979-24A4C8BD-1660-43B3-8344-963EAA681FFC

Q33237979-281009D4-FB7F-4B57-A163-7644295B493C

Q33237979-354855DD-7E29-4D05-B1EF-0B67FDFEC121

Q33237979-374120CD-4EA8-46EB-B006-455911DD8D6F

Q33237979-40DD5122-23D2-4194-858F-A09F961468C5

Q33237979-4FB91E60-7B64-45BD-8E3E-234290A34CFF

P2888

Q33237979-5244EE08-D76D-412B-94B1-286A74408479

P304

Q33237979-4E24B97C-8851-44B1-9E30-CAB69D77E979

P31

Q33237979-96DE550F-0A71-4286-B4C0-DDD037A0BB65

P356

Q33237979-C508883C-112B-442B-B49B-57213EAF150E

P433

Q33237979-E001C802-6D3D-43A1-B511-31B05A1D4EAC

P478

Q33237979-8FFDCAA7-B179-4E8E-B178-3BBF05578CCC

P50

Q33237979-10ADA3B8-88E7-4BD5-AA1F-2503D3428930

Q33237979-6C04C019-523F-4C52-9C9D-0ADDAD972A69

Q33237979-A6D28785-8E30-4397-B3A7-B253803BF396

P577

Q33237979-8A0AE601-0154-4AF1-9322-C5382138389B

P5875

Q33237979-1EDB6503-8873-4497-B0ED-64E565DBF52A

P698

Q33237979-CB9D916E-3A14-42C7-BE9D-5EB5F6F671BA

P356

P1433

P1476

EIAV vector-mediated delivery ...... rmeability in experimental CNV

@en

P2093

A J Smith

http://www.w3.org/2001/XMLSchema#string

K Binley

http://www.w3.org/2001/XMLSchema#string

K S Balaggan

http://www.w3.org/2001/XMLSchema#string

M Esapa

http://www.w3.org/2001/XMLSchema#string

O Kan

http://www.w3.org/2001/XMLSchema#string

R R Ali

http://www.w3.org/2001/XMLSchema#string

S E Barker

http://www.w3.org/2001/XMLSchema#string

S Iqball

http://www.w3.org/2001/XMLSchema#string

S Naylor

http://www.w3.org/2001/XMLSchema#string

Y Duran

http://www.w3.org/2001/XMLSchema#string

P2860

Angiostatin binds ATP synthase on the surface of human endothelial cells

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Interaction of endostatin with integrins implicated in angiogenesis

Cell surface glypicans are low-affinity endostatin receptors

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

Angiostatin effects on endothelial cells mediated by ceramide and RhoA.

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin.

Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.

P2888

P304

1153-1165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3302769

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Rachael A. Pearson

Robert E. MacLaren

James W. Bainbridge

P577

2006-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7207598

http://www.w3.org/2001/XMLSchema#string

P698

16572190

http://www.w3.org/2001/XMLSchema#string